Pharmafile Logo
Pharmafocus logo
Advanced Search

New starters at Double Helix

pharmafile | February 25, 2010 | Appointment | Sales and Marketing |  Double Helix, appointment, sales and marketing 

Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive.

The two join Double Helix’s strategic market research team, which is headquartered in London.

Amanda has eight years experience of pharmaceutical market research and is rejoining the firm after taking an extended maternity leave.

Advertisement

Ioanna, who has a Biological Sciences (Pharmacology) degree from University of Edinburgh, joins the company from Gentactis.

Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025